3 ms·
1. Invest 50% in an index fund 2. For the short term gains, Gilead sciences, and other antiviral makers, even generic chloroquine & friends, are likely to gain
by throwGuardian 7y ago
1. Invest 50% in an index fund
2. For the short term gains, Gilead sciences, and other antiviral makers, even generic chloroquine & friends, are likely to gain FDA approval for CV.
3. Ventilator makers and even CPAP manufacturers are likely to see a massive spike in demand
Donate your gains from #2, #3 to needy CV patients/health Care centres